Founded in 2014, Burrell International Group, LLC is a women owned small business providing strategic business development consulting, government relations and government marketing for clients in biotech, public health, defense, research and development, energy and cyber security arena.
BIG, LLC provides services in:
- Strategic Business Development: helping clients plan, educate, advise, assist, and advocate to key government officials and industry leaders
- Representing Client interests to government and industry partners
- Federal, State and Local Lobbying
- Coalition Building and Grassroots Support
- Issue Advocacy and Tracking
- Creating and Implementing Strategies for Amending Legislation and Regulations
- Organizing Small Business Outreach Events
BIG, LLC President, Deborah Burrell, assists clients in effectively developing and implementing strategies for amending legislation, securing funding for projects and programs, and for revising federal regulations. Combining her deep understanding of Congress and federal agencies from her 18+ years of experience as a senior staffer on Capitol Hill with Congressman Roscoe Bartlett, and 3+ years consulting for various small businesses and coalitions, BIG, LLC extensive personal knowledge of the individuals and procedures at all levels of government and industry makes the firm a highly valuable resource for clients.
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) was established in January 1969 and is the preeminent, national research laboratory for providing medical research against biological threats. It is the lead laboratory for the U.S. Biological Defense Research Program and plays a key role as the only laboratory in the U.S. Department of Defense capable of handling highly hazardous biologics. Some of its key successes have been the development of vaccines for Marburg hemorrhagic fever, Venezuelan equine encephalitis, Rift Valley Fever, tularemia, ricin, and staphylococcal enterotoxins and the development of quick and effective diagnostics for monkeypox, SARS, West Nile virus, and hantavirus. Besides cutting-edge research, the USAMRIID also performs clinical and outpatient studies to evaluate potential therapeutics. BioFactura is in close collaboration with the USAMRIID on developing and commercializing a drug for treating smallpox and ebola.
The Maryland Technology Enterprise Institute (MTECH) operates under the Clark School of Engineering of the University of Maryland. MTECH accelerates the spread of innovation to Maryland companies by developing academic-industry partnerships. BioFactura has attained a signed agreement for the use of MTECH’s Bioprocess Scale-Up Facility (BSF). The BSF is a modern bioprocessing laboratory with a wide spectrum of biomanufacturing capabilities on small- and large-scales. Processes from the BSF are directly transferable to partners operating under cGMPs for use in FDA-approved clinical trials.
